EXACT Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $13.1M

  • Investors
  • 6

EXACT Therapeutics General Information

Description

Exact Therapeutics AS is a clinical-stage biotechnology company focused on developing Acoustic Cluster Therapy (ACT), a non-invasive ultrasound-mediated technology for targeted enhancement of therapeutic agents. Its ACT platform (PS101) is being evaluated mainly in oncology, including pancreatic cancer and liver metastases, with additional applications in immuno-oncology, gene therapy, and central nervous system disorders.

Contact Information

Website
www.exact-tx.com
Formerly Known As
Phoenix Solutions, Nycomed Imaging AS
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Østre Aker vei 19
  • 0581 Oslo
  • Norway
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Østre Aker vei 19
  • 0581 Oslo
  • Norway

EXACT Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EXACT Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. PIPE 03-Dec-2024 $13.1M Completed Generating Revenue
11. PIPE 30-Nov-2023 Completed Generating Revenue
10. PIPE 14-Jul-2020 Completed Generating Revenue
9. IPO 14-Jul-2020 Completed Generating Revenue
8. Later Stage VC (Series C) 28-Nov-2018 Completed Generating Revenue
7. Early Stage VC (Series B) 01-Dec-2017 Completed Generating Revenue
6. Seed Round 30-Mar-2017 Completed Generating Revenue
5. Early Stage VC 01-Mar-2017 Completed Generating Revenue
4. Grant 24-Jan-2017 $1.87M Completed Generating Revenue
3. Angel (individual) 21-Dec-2016 Completed Generating Revenue
To view EXACT Therapeutics’s complete valuation and funding history, request access »

EXACT Therapeutics Patents

  • 51

    Total Documents Applications and Grants

  • Total Patents Families

  • 32

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

EXACT Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023372348-A1 Method and system for calculating a point estimate of an ultrasound dose Active 04-Nov-2022
AU-2023372348-B2 Method and system for calculating a point estimate of an ultrasound dose Active 04-Nov-2022
EP-4565140-A1 Method and system for calculating a point estimate of an ultrasound dose Active 04-Nov-2022
EP-4565140-B1 Method and system for calculating a point estimate of an ultrasound dose Active 04-Nov-2022
EP-4565140-C0 Method and system for calculating a point estimate of an ultrasound dose Active 04-Nov-2022 G06T7/11
To view EXACT Therapeutics’s complete patent history, request access »

EXACT Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EXACT Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Canica PE/Buyout Minority
Helene Sundt Corporation Minority
Sundt Other Minority
TRK Group Venture Capital Minority
Investinor Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

EXACT Therapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view EXACT Therapeutics’s complete esg history, request access »

EXACT Therapeutics FAQs

  • When was EXACT Therapeutics founded?

    EXACT Therapeutics was founded in 2012.

  • Where is EXACT Therapeutics headquartered?

    EXACT Therapeutics is headquartered in Oslo, Norway.

  • What is the size of EXACT Therapeutics?

    EXACT Therapeutics has 12 total employees.

  • What industry is EXACT Therapeutics in?

    EXACT Therapeutics’s primary industry is Drug Delivery.

  • Is EXACT Therapeutics a private or public company?

    EXACT Therapeutics is a Private company.

  • What is EXACT Therapeutics’s current revenue?

    The current revenue for EXACT Therapeutics is .

  • How much funding has EXACT Therapeutics raised over time?

    EXACT Therapeutics has raised $46.6M.

  • Who are EXACT Therapeutics’s investors?

    Canica, Helene Sundt, Sundt, TRK Group, and Investinor are 5 of 6 investors who have invested in EXACT Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process